Prime Medicine GAAP EPS of -$0.32 misses by $0.06, revenue of $1.2M misses by $1.6M
Source: SeekingAlpha
2025-11-07 13:45:30 ET
More on Prime Medicine
- Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now
- Prime Medicine, Inc. (PRME) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Prime Medicine, Inc. (PRME) Presents At Citi's Biopharma Back To School Conference Transcript
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
Read the full article on Seeking Alpha
For further details see:
Prime Medicine GAAP EPS of -$0.32 misses by $0.06, revenue of $1.2M misses by $1.6M
First Trust Heitman Global Prime Real Estate ETF
NASDAQ: PRME
PRME Trading
1.94% G/L:
$4.195 Last:
948,262 Volume:
$4.16 Open:
PRME Latest News
March 03, 2026 08:00:00 am
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
PRME Stock Data
$629,079,643
97,403,551
13.07%
59
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
